|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,310,000,000 |
Market
Cap: |
75.35(B) |
Last
Volume: |
13,973,164 |
Avg
Vol: |
7,738,395 |
52
Week Range: |
$54.91 - $81.42 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : 10.7 |
Insider 6 Months : 10.7 |
Insider 3/6 Months : 21.5 |
|
Guru Rank Number : 214 |
Guru Rank Value : 5.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
10,181 |
10,181 |
12,181 |
26,181 |
Total Buy Value |
$554,173 |
$554,173 |
$695,103 |
$1,671,670 |
Total People Bought |
2 |
2 |
2 |
3 |
Total Buy Transactions |
2 |
2 |
3 |
4 |
Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
Total People Sold |
1 |
1 |
2 |
5 |
Total Sell Transactions |
1 |
1 |
2 |
7 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Roberts Jonathan C |
EVP & Chief Operating Officer |
|
2017-09-18 |
4 |
AS |
$83.14 |
$7,128,673 |
D/D |
(85,743) |
33,812 |
|
- |
|
Roberts Jonathan C |
EVP & Chief Operating Officer |
|
2017-09-18 |
4 |
OE |
$34.96 |
$2,997,575 |
D/D |
85,743 |
119,555 |
|
- |
|
Foulkes Helena |
EVP & President-CVS Pharmacy |
|
2017-09-15 |
4 |
AS |
$81.88 |
$3,221,159 |
D/D |
(39,340) |
44,997 |
|
- |
|
Foulkes Helena |
EVP & President-CVS Pharmacy |
|
2017-09-15 |
4 |
OE |
$54.53 |
$2,145,210 |
D/D |
39,340 |
84,337 |
|
- |
|
Merlo Larry J |
President and CEO |
|
2017-09-13 |
4 |
AS |
$83.07 |
$20,032,331 |
D/D |
(241,150) |
299,255 |
|
- |
|
Merlo Larry J |
President and CEO |
|
2017-09-13 |
4 |
OE |
$34.96 |
$8,430,604 |
D/D |
241,150 |
540,405 |
|
- |
|
Denton David M |
EVP and CFO |
|
2017-09-11 |
4 |
AS |
$79.61 |
$18,882,214 |
D/D |
(237,078) |
36,056 |
|
- |
|
Denton David M |
EVP and CFO |
|
2017-09-11 |
4 |
OE |
$54.53 |
$5,899,219 |
D/D |
108,183 |
144,239 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2017-09-11 |
4 |
AS |
$79.61 |
$7,186,156 |
D/D |
(90,267) |
29,009 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2017-09-11 |
4 |
OE |
$48.67 |
$4,681,455 |
D/D |
90,267 |
78,183 |
|
- |
|
Merlo Larry J |
President and CEO |
|
2017-08-23 |
4 |
GD |
$77.61 |
$1,099,190 |
D/D |
14,163 |
299,255 |
|
- |
|
Swift Richard J |
Director |
|
2017-08-16 |
4 |
S |
$79.62 |
$199,050 |
D/D |
(2,500) |
3,258 |
|
- |
|
Foulkes Helena |
EVP, President-CVS Pharmacy |
|
2017-06-26 |
4 |
AS |
$80.00 |
$1,626,640 |
D/D |
(20,333) |
44,997 |
|
- |
|
Foulkes Helena |
EVP, President-CVS Pharmacy |
|
2017-06-26 |
4 |
OE |
$34.96 |
$710,842 |
D/D |
20,333 |
65,330 |
|
- |
|
Foulkes Helena |
EVP, President-CVS Pharmacy |
|
2017-06-19 |
4 |
AS |
$76.98 |
$1,565,157 |
D/D |
(20,332) |
44,997 |
|
- |
|
Foulkes Helena |
EVP, President-CVS Pharmacy |
|
2017-06-19 |
4 |
OE |
$34.96 |
$710,807 |
D/D |
20,332 |
65,329 |
|
- |
|
Denton David M |
EVP and CFO |
|
2017-06-12 |
4 |
AS |
$80.00 |
$18,440,800 |
D/D |
(230,510) |
164,563 |
|
- |
|
Denton David M |
EVP and CFO |
|
2017-06-12 |
4 |
OE |
$34.96 |
$9,246,024 |
D/D |
230,510 |
395,073 |
|
- |
|
Dorman David W |
Director |
|
2017-05-10 |
4 |
A |
$80.94 |
$284,990 |
D/D |
3,521 |
76,207 |
|
- |
|
Deparle Nancy Ann |
Director |
|
2017-05-10 |
4 |
A |
$80.94 |
$104,979 |
D/D |
1,297 |
7,892 |
|
- |
|
Bracken Richard M |
Director |
|
2017-05-10 |
4 |
A |
$80.94 |
$112,426 |
D/D |
1,389 |
6,633 |
|
- |
|
White Tony L |
Director |
|
2017-05-10 |
4 |
A |
$80.94 |
$104,979 |
D/D |
1,297 |
22,999 |
|
- |
|
Millon Jean Pierre |
Director |
|
2017-05-10 |
4 |
A |
$80.94 |
$104,979 |
D/D |
1,297 |
1,297 |
|
- |
|
Boratto Eva C |
EVP, Cont & Chief Acct Officer |
|
2017-04-03 |
4 |
A |
$78.05 |
$349,976 |
D/D |
4,484 |
15,674 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2017-04-03 |
4 |
A |
$78.05 |
$1,249,971 |
D/D |
16,015 |
43,668 |
|
- |
|
711 Records found
|
|
Page 19 of 29 |
|
|